Pfizer Unveils Positive Results From Phase 3 Study Of Prevnar 20
12/1 14:05
(RTTNews) - Pharma major Pfizer Inc. (PFE) on Wednesday unveiled positive top-line results from a Phase 3 study, describing the safety and immunogenicity of Prevnar 20, a pneumococcal conjugate vaccine....